Simultaneous quantification of 14 key rat T helper cytokines — covering Th1, Th2, and Th17 axes plus myeloid growth factors — in a single well using Luminex xMAP technology. Designed for comprehensive preclinical T cell immunology, vaccine studies, and immune response profiling in rat models.
T helper (Th) cells are the orchestrators of adaptive immunity, directing the character of the immune response through the cytokines they secrete. Th1 cells produce IFN-γ, IL-2, and TNF-α to drive cell-mediated immunity against intracellular pathogens and tumors. Th2 cells produce IL-4, IL-5, and IL-13 to drive humoral immunity against extracellular parasites and allergens. Th17 cells produce IL-17A to drive neutrophil-mediated inflammation and mucosal antifungal defense. The balance among these T helper subsets — Th1/Th2 ratio and Th17 axis — determines the character of the immune response, and its dysregulation underlies autoimmune disease, allergy, and impaired anti-tumor immunity.
Creative Proteomics offers the Rat Th1/Th2/Th17 Cytokine 14-Plex Panel based on the Luminex xMAP platform for simultaneous quantification of 14 key T helper cytokines in a single well. The panel covers Th1 cytokines (IFN-γ, IL-2, IL-12p70, TNF-α), Th2 cytokines (IL-4, IL-5, IL-10, IL-13), Th17 effector (IL-17A), pro-inflammatory mediators (IL-1α, IL-1β, IL-6), and myeloid growth factors (GM-CSF, G-CSF) — providing complete coverage of the T helper polarization spectrum in a single well. The panel is available as a focused Th1/Th2 12-plex subset or the full 14-plex. Validated for serum, plasma, and cell culture supernatants, the panel is compatible with MAGPIX, Luminex 200, and FLEXMAP 3D systems.
The panel is backed by validated performance data with intra-assay CV <10% and broad dynamic range, enabling accurate quantitation from a single 25 μL sample. It includes the full analyte set of the widely cited Th panel format used in hundreds of published rat immunology studies, plus G-CSF for myeloid activation context.
The Rat Th1/Th2/Th17 14-Plex Panel covers the full Th1/Th2/Th17 spectrum plus key pro-inflammatory mediators and myeloid growth factors. The 12-plex Th1/Th2 subset (excluding IL-17A and G-CSF) is also available.
| Target | Alternative Name | T Helper Axis | Biological Function |
|---|---|---|---|
| IFN-γ | Interferon-gamma, Type II IFN | Th1 | Signature Th1 cytokine; activates macrophages for enhanced microbicidal activity and antigen presentation; upregulates MHC class I and II; promotes IgG2a class switching in rodents; elevated in autoimmune and infectious disease models |
| IL-2 | Interleukin-2, T Cell Growth Factor | Th1 / Treg | Primary T cell growth factor driving clonal expansion of activated T cells; also essential for regulatory T cell (Treg) maintenance and peripheral tolerance; IL-2/IL-2R axis is a therapeutic target in transplantation and autoimmunity |
| IL-12p70 | Interleukin-12 p70 | Th1 Polarization | Heterodimeric cytokine (p35 + p40 subunits); master inducer of Th1 differentiation; stimulates IFN-γ production from NK and T cells; bridges innate sensing to adaptive immunity; p40 subunit shared with IL-23 |
| TNF-α | Tumor Necrosis Factor-alpha, Cachectin | Th1 / Pro-Inflammatory | Early-response cytokine produced by activated macrophages and Th1 cells; drives endothelial activation, vascular permeability, and neutrophil recruitment; key therapeutic target in RA, IBD, and psoriasis models |
| IL-4 | Interleukin-4, B Cell Stimulatory Factor-1 | Th2 | Signature Th2 cytokine; drives naive CD4+ T cell differentiation toward Th2 phenotype; promotes B cell class switching to IgG1 and IgE; suppresses Th1 differentiation; central to allergic and anti-parasitic responses |
| IL-5 | Interleukin-5, Eosinophil Differentiation Factor | Th2 | Eosinophil growth, differentiation, and activation factor; promotes IgA production by B cells; elevated in allergic airway inflammation and parasitic helminth infection models |
| IL-10 | Interleukin-10, CSIF | Th2 / Treg | Prototypic anti-inflammatory cytokine; suppresses macrophage and dendritic cell function; inhibits IL-12, TNF-α, and IFN-γ production; essential for immune homeostasis and resolution of inflammation |
| IL-13 | Interleukin-13 | Th2 | Shares IL-4Rα signaling chain with IL-4; drives goblet cell metaplasia, mucus hypersecretion, and airway hyperresponsiveness; central effector in allergic asthma models; promotes collagen deposition and fibrosis |
| IL-17A | Interleukin-17A, CTLA-8 | Th17 | Signature Th17 cytokine; induces neutrophil-recruiting chemokines (CXCL1, CXCL8), G-CSF, and antimicrobial peptides from epithelial and stromal cells; critical for mucosal antifungal defense and barrier immunity; pathogenic in psoriasis, RA, EAE, and IBD models |
| GM-CSF | Granulocyte-Macrophage Colony-Stimulating Factor | T Cell / Myeloid | Growth factor for granulocyte and macrophage lineages; produced by activated T cells; promotes dendritic cell maturation and antigen presentation; links T cell activation to myeloid effector recruitment |
| G-CSF | Granulocyte Colony-Stimulating Factor, CSF-3 | Myeloid Growth Factor | Primary regulator of neutrophil production and mobilization from bone marrow; induced by IL-17A in stromal and epithelial cells; elevated in bacterial infection, sterile inflammation, and Th17-driven pathology; provides myeloid context to the T helper cytokine profile |
| IL-1α | Interleukin-1 alpha, IL-1F1 | Pro-Inflammatory | Constitutively expressed alarmin released upon cell damage/necrosis; activates IL-1R1 to initiate sterile inflammation; unlike IL-1β, does not require inflammasome processing for activity |
| IL-1β | Interleukin-1 beta, IL-1F2 | Pro-Inflammatory | Prototypic inflammasome-dependent cytokine; cleaved by caspase-1 following NLRP3/AIM2/NLRC4 activation; potent pyrogen driving fever and acute-phase protein synthesis |
| IL-6 | Interleukin-6, BSF-2 | Pro-Inflammatory / Th17 | Master coordinator of the acute-phase response; induces hepatic CRP and fibrinogen; drives Th17 differentiation in combination with TGF-β1; promotes B cell antibody secretion |
Validated performance parameters for the Rat Th1/Th2/Th17 Cytokine 14-Plex Panel. The 12-plex Th1/Th2 subset shares identical specifications.
T helper polarization is defined by the relative levels of multiple cytokines across Th1, Th2, and Th17 axes. Luminex multiplex captures the full Th polarization profile from a single sample.
| Parameter | Luminex 14-Plex | Traditional ELISA (14 assays) |
|---|---|---|
| Targets per Well | 14 | 1 |
| Sample Volume | 25 μL | 350–700 μL total |
| Assay Time | ~4 hours | 42–56 hours total |
| Th Polarization Insight | Th1/Th2 ratio + Th17 axis from same aliquot | Requires 3+ separate assays; between-assay CV invalidates ratios |
| Comprehensive Profiling | All 14 cytokines from one 96-well plate | 14 plates with different standard curves and QC |
The IFN-γ/IL-4 ratio remains the gold standard index of Th1/Th2 balance in rodent immunology. The IL-17A measurement adds the critical Th17 dimension — elevated IL-17A with normal IL-4 distinguishes Th17-driven autoimmune pathology (psoriasis, EAE) from Th2-driven allergic disease, with direct implications for therapeutic strategy (anti-IL-17 vs. anti-IL-4/IL-13). The 14-plex panel captures all three T helper axes from a single 25 μL sample, eliminating the between-assay variability that would invalidate cross-axis comparisons if measured by separate ELISAs.
Proper sample collection and handling are critical for accurate T helper cytokine measurement. Th2 and Th17 cytokines (IL-4, IL-5, IL-13, IL-17A) are typically at lower concentrations than Th1 cytokines and require careful handling.
| Sample Type | Volume | Requirement |
|---|---|---|
| Serum | 25 μL | Collect in SST tubes; allow clotting for 30 min at room temperature; centrifuge at 1,500g for 10 min. Serial sampling via tail vein for longitudinal Th polarization studies. |
| EDTA/Heparin Plasma | 25 μL | Centrifuge within 30 min at 2,500g for 15 min; platelet-poor plasma recommended to minimize platelet-derived cytokines (TNF-α, IL-1β) |
| Splenocyte Culture Supernatant | 50 μL | Stimulate with PMA/ionomycin or anti-CD3/CD28 for 24–72 hours; centrifuge at 10,000g for 10 min; the gold standard for ex vivo Th1/Th2 polarization assessment |
| Lymph Node Cell Supernatant | 50 μL | Same stimulation protocol as splenocytes; draining lymph nodes preferred for antigen-specific T cell responses |
| Minimum Project Size | — | One 96-well plate; smaller batches accepted with surcharge |
| Sample Storage | — | -80°C; avoid repeated freeze-thaw (>2 cycles may degrade IL-4 and IL-13 disproportionately vs. IFN-γ, artifactually skewing Th1/Th2 ratios) |
| Shipping | — | Dry ice; samples must remain frozen throughout transit |
The T helper response is not binary — it exists on a Th1-Th2-Th17 continuum with myeloid context. The 14-plex panel provides four layers of information about the T helper polarization state.
IFN-γ, IL-2, IL-12p70, TNF-α — cell-mediated immunity driven by Th1-polarized CD4+ T cells. IFN-γ is the signature cytokine activating macrophages. IL-12p70 is the master inducer driving naive T cells toward Th1. 25 μL per well.
IL-4, IL-5, IL-10, IL-13 — humoral immunity and allergic inflammation. IL-4 is the master inducer of Th2 differentiation. IL-5 drives eosinophilia. IL-13 drives mucus production and fibrosis. 25 μL per well.
IL-17A, IL-6, G-CSF, GM-CSF — IL-17A is the signature Th17 cytokine driving neutrophil-mediated inflammation. G-CSF is the key downstream effector induced by IL-17A in stromal cells. IL-6 (with TGF-β1) drives Th17 differentiation. 25 μL per well.
The Rat Th1/Th2/Th17 14-Plex Panel supports preclinical research across T cell immunology, vaccine development, autoimmunity, and infectious disease.
Rat models of rheumatoid arthritis (CIA), multiple sclerosis (EAE), and type 1 diabetes (BB rat, STZ) are characterized by Th1/Th17-skewed cytokine profiles. The 14-plex panel quantifies the Th1 (IFN-γ, IL-2, TNF-α) and Th2 (IL-4, IL-10) balance at baseline, during disease induction, and in response to immunomodulatory therapy from serial serum or splenocyte samples.
Vaccine adjuvants are classified by their ability to polarize T helper responses: alum drives Th2 (IL-4, IL-5 dominant), CpG and poly I:C drive Th1 (IFN-γ, IL-12 dominant). The 12-plex panel profiles the Th1/Th2 cytokine signature induced by candidate adjuvants and vaccine formulations in rat models, providing quantitative, multiplexed readouts of T helper polarization.
Ovalbumin (OVA)-induced allergic airway inflammation in Brown Norway rats is the classic Th2-driven model. IL-4, IL-5, and IL-13 are the central effector cytokines driving IgE production, eosinophil recruitment, and airway hyperresponsiveness. The panel quantifies all three Th2 cytokines alongside Th1 counter-regulators (IFN-γ) from BAL fluid, serum, and lung homogenates.
Acute allograft rejection is Th1-driven (IFN-γ, IL-2 dominant), while Th2 polarization (IL-4, IL-10) is associated with graft acceptance and tolerance. The panel enables serial monitoring of the Th1/Th2 balance in rat models of heart, kidney, and liver transplantation to assess immunosuppressive regimen efficacy and tolerance induction.
Intracellular pathogens (Listeria, Toxoplasma) require Th1 responses for clearance (IFN-γ-mediated macrophage activation). Helminth infections (Nippostrongylus, Trichinella) drive Th2 responses (IL-4, IL-5, IL-13 for IgE and eosinophil-mediated expulsion). The 12-plex panel distinguishes Th1-adequate from Th1-deficient responses in infection models.
Drug-induced immunomodulation is a key safety concern in preclinical development. The 12-plex panel provides a standardized Th1/Th2 cytokine profile for immunotoxicity assessment — detecting unintended Th1 suppression (increased infection risk) or Th2 skewing (allergy/autoimmunity risk) in response to candidate therapeutic compounds.
Every Luminex rat Th1/Th2 cytokine assay includes a comprehensive data package with full quality control documentation.
Explore other Luminex panels available for rat immunology and preclinical research.
Common questions about our rat Th complete cytokine Luminex multiplex panel service.
Contact us to discuss your rat immunology study requirements, panel configuration (14-plex Th1/Th2/Th17 or 12-plex Th1/Th2 subset), and sample collection protocols. We respond within 24 hours.
Request a QuoteOnline Inquiry
×